期刊文献+

HSV-1 UL-12基因的克隆、表达及产物复性 被引量:1

Clone and Expression of HSV-1 UL-12 Gene and Product-renaturing
下载PDF
导出
摘要 目的:克隆及表达单纯疱疹病毒Ⅰ型(HSV-1)UL12基因,对其表达产物HSV-1碱性核酸酶(AN)进行复性,为建立抗HSV-1药物的分子筛选模型奠定了基础,对于寻找抗病毒药物具有重要意义。方法:从HSV-1感染的Vero细胞中提取HSV-1基因组DNA,通过PCR克隆出UL12基因并对其测序;然后将HSV-1 UL12基因先克隆至pMD19-T载体,再亚克隆到pET32a表达载体上,并将重组载体转化到E.coli Rosetta菌中进行表达;最后用梯度盐酸胍对表达出的包涵体进行复性。结果:成功构建了pET32a-UL12重组载体,经序列比对,与GenBank上公布的HSV-1国际标准毒株17株的UL12基因序列的同源性达到了99.2%。在E.coli Rosetta菌中以包涵体的形式表达,经复性得到有活性的HSV-1碱性核酸酶(AN)。AN同时具有核酸外切酶和核酸内切酶的活性,与核酸作用60min时酶活性最高。结论:重组载体pET32a-UL12经表达、复性可获得有活性的HSV-1 AN。 Objective: Cloning of UL12 gene from herpes simplex virus type 1,was the foundation of establishing molecular models for HSV-1 drug screening.Method: The HSV-1 genome was extracted from Vero cells infected with HSV-1,plus,UL12 gene was amplified by PCR and then sequenced;HSV-1 UL12 was firstly cloned into pMD19-T vector and then subcloned into pET32a expression vector,and the recombinant vector was transformed into E.coli Rosetta bacteria to express;finally,the inclusion bodies expressed were renatured by a gradient of guanidine hydrochloride.Result: The HSV-1 UL12 gene has been successfully cloned and shares 99.2% of sequence alignment with the international standard HSV-1 stain 17.The HSV-1 alkaline nuclease expressed in inclusion bodies in E.coli Rosetta bacteria had both exonuclease and endonuclease activities after renaturation,which reached a highest activity when it acted on DNA for 60min.Conclusion: HSV-1 AN with biological activity was obtained after the recombinant vector pET32a-UL12 was expressed and renatured.
出处 《生物技术》 CAS CSCD 北大核心 2011年第2期15-18,共4页 Biotechnology
基金 国家自然科学基金面上项目("膳食黑米花青素BRACs防护视网膜光化学损伤及分子机制研究" 30972462) 四川省杰出青年科技基金项目("抗HSV-1药物碱性核酸酶分子筛选模型的建立" 06ZQ026-024) 成都医学院创新性实验项目(No.CX2010024/CX2010037)资助
关键词 HSV-1 UL12基因 克隆 表达 复性 HSV-1 UL12 gene clone expression renaturation
  • 相关文献

参考文献11

  • 1Hsiong CY,Ho TY.Emodin is a novel alkaline nuelease inhibitor that suppresses herpes simplex virus type 1 yields in cell cultures[J].Br JPharmacol,2008,155:227-235.
  • 2Keir HM,Gold E.Deoxyribonucleic acid nucleotidyltransferase and deoxyribonuclease from cultured cells infected with herpes simplex virus[J].J Biochim.Biophys Acta,1963,72:263-276.
  • 3Coreoran JA,Saffran HA,Duguay BA,Smiley JR.Herpes simplex virus UL12.5 targets mitochondriathrough a mitochondrial localization sequence proximal to the N terminus[J].J Virol,2009,83:2601-2610.
  • 4Brodtkorb E,Lindqvist M,Jonsson M,et al.Diagnosis of herpes simplex encephalitis.A comparison between electron phalography and computed tomography findings[J].J Acts Neurol Scand,1982,66(4):462-471.
  • 5Amstey MS,Monif GR,Pahmias AJ,et al.Cesarean section and genitul herpes virus infection[J].J Obstet Gynecol,1979,53(5):641-642.
  • 6Weller SK,Seghatoleslami M R,Shao L,et al.The herpes simplex virus type 1 alkaline nuclease is not essential for viral DNA synthesis:isolation and characterization of a lacZ insertion mutant[J].J Gen Virol,1990,71:2941-2952.
  • 7Nina Bacher Reuven,Amy E.Stairs,Richard S.Myers,et al.Weller.The herpes simplex virus Type 1 alkaline nuclease and single-stranded DNA binding protein mediate strand exchange in vitro[J].J Virol,2003,7425-7433.
  • 8Abrantes JL,Barbosa J,Cavalcanti D,Pereira RC,Frederico Fontes CL,Teixeira VL,Moreno Souza TL,Paixao IC.The effects of the ditepenes isolated from the Brazilian brown algae Dictyota pfaffii and Dictyota menstrualis against the herpes simplex type-1 replicative cycle[J].Planta Med,2010,76:339-344.
  • 9Sagou K,Uema M,Kawaguehi Y.Nucleolin is required for efficiont nuclear egress of herpes simplex virus type 1 nucleocapsids[J].J Virol,2010,84:2110-2121.
  • 10何秋璟,张春龙,仁哲,张美英,朱钦昌,刘秋英,张佩琢,王一飞.HSV-1 UL30基因cDNA的克隆及筛选有效siRNA的融合载体构建[J].生物技术,2008,18(3):1-4. 被引量:1

二级参考文献6

同被引文献20

  • 1张仁怀,王海燕,谈宁馨,张风豪,张义正.豆豉溶栓酶基因在毕赤酵母中的表达及其产物的纯化[J].应用与环境生物学报,2005,11(5):623-626. 被引量:18
  • 2F奥斯伯,R布伦特,R E金斯顿,等.精编分子生物学实验指南[M]//颜子颖,王海林,译.北京:科学出版社,1998.
  • 3Jalouli M M, Jalouli J, Hasseus B, et al. Nested PCR for detection of HSV-1 in oral mucosa[J]. Med Oral Patol Oral Cir Bucal, 2015, 20(6): e664-e669.
  • 4Langenberg A G, Corey L, Ashley R L, et al. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiton HSV Vaccine Study Group[J]. N Engl J Med, 1999, 341(19)- 1432-1438.
  • 5Meurman J H. Infectious and dietary risk factors of oral cancer[J]. Oral Oncol, 2010, 46(6): 411-413.
  • 6Lou E, Kellman R M, Shillitoe E J. Effect of herpes simplex virus type-I on growth of oral cancer in an immunocompetent, orthotopic mouse model[J]. Oral Oncol, 2002, 38(4): 349-356.
  • 7Martinez R, Shao L, Bronstein J C, et al. The product of a 1.9-kb mRNA which overlaps the HSV-I alkaline nuclease gene (ULI2-2) cannot relieve the growth defects of a null mutant[J]. Virolog3,, 1996, 215(2): 152-164.
  • 8Goldstein J N, Weller S K. The exonuclease activity of HSV- 1 UL 12-2 is required for in vivo function[J]. Virolog3,, 1998, 244(2): 442-457.
  • 9Cunha C W, Taylor K E, Pritchard S M, et al. Widely used herpes simplex virus 1 ICP0 deletion mutant strain d11403 and its derivative viruses do not express glycoprotein C due to a secondary mutation in the gC gene[J]. Plos One, 2015+ 10(7): e131129.
  • 10Fujii H, Kato A, Mugitani M, et al. The ULI2-2 protein of herpes simplex virus 1 is regulated by tyrosine phosphorylation[J]. J Virol, 2014, 88( 18): 10624-10634.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部